Literature DB >> 4703066

Use of cholestyramine in treatment of children with familial hypercholesterolaemia.

R J West, J K Lloyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4703066      PMCID： PMC1648381          DOI： 10.1136/adc.48.5.370

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  16 in total

Review 1.  Atherosclerosis as a pediatric problem.

Authors:  W B Kannel; T R Dawber
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

2.  Treatment of familial hypercholesterolaemia in children.

Authors:  M M Segall; A S Fosbrooke; J K Lloyd; O H Wolff
Journal:  Lancet       Date:  1970-03-28       Impact factor: 79.321

3.  Treatment of essential hyperlipidaemia.

Authors:  E M Jepson; M F Fahmy; P E Torrens; J D Billimoria; N F Maclagan
Journal:  Lancet       Date:  1969-12-20       Impact factor: 79.321

4.  Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states.

Authors:  J Slack
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

5.  Treatment of essential hyperlipidaemia.

Authors:  D S Fredrickson; R I Levy
Journal:  Lancet       Date:  1970-01-24       Impact factor: 79.321

6.  A paediatric approach to the prevention of atherosclerosis.

Authors:  J K Lloyd; O H Wolff
Journal:  J Atheroscler Res       Date:  1969 Sep-Oct

7.  Response of hyperlipoproteinemia to cholestyramine resin.

Authors:  H J Fallon; J W Woods
Journal:  JAMA       Date:  1968-06-24       Impact factor: 56.272

8.  Improved precision for the autoanalyser determination of serum cholesterol.

Authors:  A S Fosbrooke; G A Pringle
Journal:  Clin Chim Acta       Date:  1970-10       Impact factor: 3.786

9.  The use of oral ion exchange resins in drug poisoning: general hypothesis and some studies on cholestyramine versus barbiturates.

Authors:  K D Edwards
Journal:  Med J Aust       Date:  1965-11-27       Impact factor: 7.738

10.  A modified method for the preparation of methyl esters of a mixture of medium-chain and long-chain fatty acids. Application to the determination of serum triglyceride and non-esterified fatty acid composition and concentration by gas-liquid chromatography.

Authors:  A S Fosbrooke; I Tamir
Journal:  Clin Chim Acta       Date:  1968       Impact factor: 3.786
View more
  12 in total

1.  Letter: Screening for hyperlipidaemia in childhood.

Authors:  J K Lloyd; A S Fosbrooke; R West; O H Wolff
Journal:  Br Med J       Date:  1975-01-04

Review 2.  Hyperlipidaemia in children.

Authors:  J K Lloyd
Journal:  Br Heart J       Date:  1975-02

3.  Hyperlipidaemia, smoking and hypertension. The place of the hyperlipidaemias.

Authors:  J K Lloyd; R J West
Journal:  Postgrad Med J       Date:  1978-03       Impact factor: 2.401

Review 4.  A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.

Authors:  S Tonstad
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

5.  Lipoprotein measurements--a necessity for precise assessment of risk in children from high-risk families.

Authors:  D Heldenberg; I Tamir; O Levtow; Y Burstein; B Werbin
Journal:  Arch Dis Child       Date:  1979-09       Impact factor: 3.791

6.  Diverticular disease: three studies. Part III - Metabolic effect of bran in patients with diverticular disease.

Authors:  A J Brodribb; D M Humphreys
Journal:  Br Med J       Date:  1976-02-21

7.  The effect of oral calcium carbonate administration on serum lipoproteins of children with familial hypercholesterolaemia (type II-A).

Authors:  P H Groot; W F Grose; R Dijkhuis-Stoffelsma; J Fernandes; J J Ambagtsheer
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

Review 8.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

9.  Primary hyperlipoproteinemia in childhood and adolescence: identification and treatment of persons at risk for premature atherosclerosis.

Authors:  V Rose; D M Allen; R G Pearse; J Chapell
Journal:  Can Med Assoc J       Date:  1976-10-23       Impact factor: 8.262

10.  Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood.

Authors:  P O Kwiterovich; D S Fredrickson; R I Levy
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.